Pulmonary fibrosis is a lung disease where the air sacs and tissue in the lungs get stiff and scarred. This makes it harder to breathe and perform everyday activities. The ...

Nerandomilast is both effective and well-tolerated, representing a "major step forward for the treatment of progressive pulmonary fibrosis (PPF)," with its effect on clinical outcomes sustained over ...

Silent lung diseases develop without symptoms and many people are unaware of the changes to their lungs. Its early symptoms are easily confused with minor maladies, causing delays in diagnosis. Early ...

Mucoactive agents did little to stave off pulmonary exacerbations of non-cystic fibrosis bronchiectasis, the CLEAR trial ...

On Saturday, community members gathered at Lions Club Park in Killeen, where they held a walk to raise awareness regarding the chronic lung disease, pulmonary fibrosis.

In her columns debut, Debbie Klein shares the story of her late husband Steve's idiopathic pulmonary fibrosis diagnosis.

Nocturnal gastro-esophageal reflux (nGER) has no significant link to pulmonary abnormalities in middle-aged adults.

Explore how machine learning is revolutionising interstitial lung disease management, enhancing early diagnosis, treatment, ...

The most common way to assess lung age is through a spirometry test. In this procedure, a person takes a deep breath and then ...

Lung fibrosis affects about 5,000 people in Ireland, but many patients are left in limbo as higher-profile respiratory illnesses are prioritised for treatment ...

Patients with IPF and emphysema who received antifibrotic agents had similar outcomes to patients with IPF alone.

For columnist Sam Kirton, Pulmonary Fibrosis Awareness Month is an opportunity to tell others about his journey.